A patient with HF has met with his primary care provider and begun treatment with an angiotensinconverting enzyme (ACE) inhibitor. When the patient begins treatment, the nurse should prioritize what assessment?

Question

Quizplus · Accepted Answer

Patients receiving ACE inhibitors are monitored for hypotension, hyperkalemia (increased potassium in the blood), and alterations in renal function. ACE inhibitors do not typically cause alterations in LOC. Oxygen saturation must be monitored in patients with HF, but this is not particular to ACE inhibitor therapy. ACE inhibitors do not normally cause nausea.

A Patient with HF Has Met with His Primary Care